References
- Rammensee H, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics41, 178–228 (1995).
- Apostolopoulos V, Haurum JS, McKenzie IF. MUC1 peptide epitopes associated with 5 different H2 class I molecules. Eur. J. Immunol.27, 2579–2587 (1997).
- Apostolopoulos V, Karanikas V, Haurum J, McKenzie IF. Induction of HLA-A2 restricted cytotoxic T lymphocytes to the MUC1 human breast cancer antigen. J. Immunol.159, 5211–5218 (1997).
- Apostolopoulos V, Chelvanayagam G, Xing PX, McKenzie IF. Anti-MUC1 antibodies react directly with MUC1 peptides presented by class I H2 and HLA molecules. J. Immunol.161, 767–775 (1998).
- Apostolopoulos V, Yu M, Corper AL et al. Crystal structure of a non-canonical low affinity peptide complexed with MHC class I: a new approach for vaccine design. J. Mol. Biol.318, 1293–1305 (2002).
- Apostolopoulos V, Yu M, Corper AL et al. Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors. J. Mol. Biol.318, 1307–1316 (2002).
- Apostolopoulos V, Yuriev E, Ramsland PA, Plebanski M, Paulsen H, McKenzie IF. A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor. Proc. Natl Acad. Sci. USA100, 15029–15034 (2003).
- Lazoura E, Lodding J, Farrugia W, Day S, Ramsland PA, Apostolopoulos V. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses. Mol. Immunol. DOI: 10.1016/j.molimm.2008.11.007 (2008) (Epub ahead of print).
- Lazoura E, Lodding J, Farrugia W et al.Enhanced class I binding and immune responses through anchor modification of the non-canonical tumour associated MUC1–8 peptide. Immunology119, 306–316 (2006).